QS Investors LLC trimmed its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 18.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 114,653 shares of the company’s stock after selling 26,692 shares during the period. QS Investors LLC’s holdings in Express Scripts were worth $8,558,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. James Investment Research Inc. raised its stake in Express Scripts by 2.2% in the fourth quarter. James Investment Research Inc. now owns 30,241 shares of the company’s stock worth $2,257,000 after buying an additional 656 shares in the last quarter. First National Bank of Omaha raised its stake in Express Scripts by 7.4% in the fourth quarter. First National Bank of Omaha now owns 11,060 shares of the company’s stock worth $825,000 after buying an additional 765 shares in the last quarter. Palladium Partners LLC raised its stake in Express Scripts by 4.1% in the fourth quarter. Palladium Partners LLC now owns 19,666 shares of the company’s stock worth $1,468,000 after buying an additional 772 shares in the last quarter. Alpha Windward LLC raised its stake in Express Scripts by 35.9% in the fourth quarter. Alpha Windward LLC now owns 2,981 shares of the company’s stock worth $223,000 after buying an additional 787 shares in the last quarter. Finally, Hendershot Investments Inc. raised its stake in Express Scripts by 1.0% in the fourth quarter. Hendershot Investments Inc. now owns 81,895 shares of the company’s stock worth $6,113,000 after buying an additional 840 shares in the last quarter. 89.08% of the stock is owned by hedge funds and other institutional investors.
Express Scripts Holding (ESRX) opened at $80.75 on Monday. The firm has a market cap of $45,319.88, a price-to-earnings ratio of 10.31, a PEG ratio of 0.99 and a beta of 0.94. Express Scripts Holding has a one year low of $55.80 and a one year high of $85.07. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67.
Express Scripts announced that its Board of Directors has initiated a share repurchase plan on Monday, December 18th that authorizes the company to repurchase 45,000,000 outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
A number of equities analysts have weighed in on ESRX shares. Maxim Group raised their target price on shares of Express Scripts from $87.00 to $101.00 in a research note on Wednesday, February 28th. TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Jefferies Group set a $80.00 target price on shares of Express Scripts and gave the company a “buy” rating in a research note on Friday, December 15th. SunTrust Banks set a $82.00 target price on shares of Express Scripts and gave the company a “buy” rating in a research note on Thursday, December 14th. Finally, BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday, December 14th. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and eight have issued a buy rating to the company’s stock. Express Scripts presently has an average rating of “Hold” and a consensus price target of $81.97.
In other news, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now owns 87,400 shares in the company, valued at $6,124,992. The disclosure for this sale can be found here. Insiders have sold a total of 21,896 shares of company stock worth $1,617,903 in the last quarter. Corporate insiders own 0.68% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding (ESRX) Stake Lowered by QS Investors LLC” was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/express-scripts-holding-esrx-stake-lowered-by-qs-investors-llc.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.